As pharmaphorum reported during ESMO 2025, fresh from a return to oncology with the FDA approval of zongertinib as a ...

Artificial intelligence and machine learning systems continue to be adopted into an ever wider array of healthcare applications, such as assisting doctors with medical image diagnostics. Capable of ...

An interview with Tracey Mullen, Chief Operating Officer at Abveris. Please give an overview of the state of immuno-oncological therapeutic antibodies being researched and on the market. The growing ...

Deviating from the most widely described approach for robot-assisted radical prostatectomy (RARP), researchers have reported the exceptional outcomes of a Retzius-sparing approach in which they pass ...

Within hematology and oncology, companion diagnostics (CDxs) play an increasing role in securing an optimal therapy for individual patients, and the US Food and Drug Administration (FDA) consider this ...

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial This study aimed to ...

EDINBURGH, Scotland, April 9, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (OTC: TCBPY) a clinical-stage biotechnology company developing platform allogeneic ...

Facing The World, in collaboration with Hong Ngoc General Hospital and the Hanoi ENT Society, hosted the conference on ...

Dr. Intezar Mehdi, Director and Head of the Department, Senior Consultant - Paediatric Haeamtology Oncology & BMT at HCG Cancer Centre, Bengaluru. When cells mutate abnormally among children, it ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. Each year, medical professionals at Tajikistan’s Republic ...